Founded in 2018, Virica has operated out of a small lab at the University of Ottawa Heart Institute since 2021. Already an Insider? Log in Get Instant Access to This Article Become an Ottawa Business Journal Insider and get immediate access to all of our Insider-only content and much more. Learn More and Become an Insider Critical Ottawa business news and analysis updated daily. Immediate access to all Insider-only content on our website. 4 issues per year of the Ottawa Business Journal magazine. Special bonus issues like the Ottawa Book of Lists. Discounted registration for OBJ’s in-person events. Click here to purchase a paywall bypass link for this article.
Ottawa risks seeing its best and brightest biotech startups leave for greener pastures because the city lacks the infrastructure to help turn promising ideas into viable commercial products, a prominent scientist and entrepreneur says.
“At the end
While about three-quarters of Virica’s 50 customers are gene therapy producers, founder and CEO Jean-Simon Diallo says his firm’s technology also accelerates the production of vaccines.
Ottawa startup announced this week it’s landed $400,000 in federal government funding to help the National Research Council of Canada develop a gene therapy to treat lipoprotein lipase deficiency.
It s in their genes: Virica Biotech partners with U K firm on cancer-fighting treatments obj.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from obj.ca Daily Mail and Mail on Sunday newspapers.